🇺🇸 FDA
Pipeline program

Ceftolozane/tazobactam

U1111-1295-4030

Approved small_molecule active

Quick answer

Ceftolozane/tazobactam for Bronchiectasis is a Approved program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Bronchiectasis
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials